The price of Metlife Inc (NYSE:MET) shares last traded on Wall Street rose 1.68% to $80.11.
MET stock price is now -3.99% away from the 50-day moving average and 5.46% away from the 200-day moving average. The market capitalization of the company currently stands at $55.47B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $97, TD Cowen recently initiated with Buy rating for Metlife Inc (NYSE: MET). On September 05, 2024, Barclays recently initiated its ‘Overweight’ rating on the stock quoting a target price of $91, while ‘Goldman’ rates the stock as ‘Buy’
In other news, DEBEL MARLENE, EVP & Chief Risk Officer sold 22,810 shares of the company’s stock on Dec 13 ’24. The stock was sold for $1,890,577 at an average price of $82.88. Upon completion of the transaction, the EVP & Chief Risk Officer now directly owns 108,507 shares in the company, valued at $8.69 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 13 ’24, President & CEO Khalaf Michel sold 20,926 shares of the business’s stock. A total of $1,733,604 was realized by selling the stock at an average price of $82.84. This leaves the insider owning 500,799 shares of the company worth $40.12 million. A total of 16.44% of the company’s stock is owned by insiders.
During the past 12 months, Metlife Inc has had a low of $64.61 and a high of $89.05. According to the stock market information, the enterprise value for the company is $128620601344, which is based on a 16.16 price-to-earnings ratio, a 1.23 price-to-earnings-growth ratio, and a beta of 1.07. The fifty day moving average price for MET is $83.442 and a two-hundred day moving average price translates $75.95935 for the stock.
The latest earnings results from Metlife Inc (NYSE: MET) was released for 2024-09-30. The net profit margin was 4.99% and return on equity was 13.31% for MET. The company reported revenue of $18.44 billion for the quarter, compared to $15.87 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 16.22 percent.
